Kallikrein 5 induces atopic dermatitis–like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Netherton syndrome (NS) is a severe genetic skin disease with constant atopic manifestations that is caused by mutations in the serine protease inhibitor Kazal-type 5 (SPINK5) gene, which encodes the protease inhibitor lymphoepithelial Kazal-type–related inhibitor (LEKTI). Lack of LEKTI causes stratum corneum detachment secondary to epidermal proteases hyperactivity. This skin barrier defect favors allergen absorption and is generally regarded as the underlying cause for atopy in NS. We show for the first time that the pro-Th2 cytokine thymic stromal lymphopoietin (TSLP), the thymus and activation-regulated chemokine, and the macrophage-derived chemokine are overexpressed in LEKTI-deficient epidermis. This is part of an original biological cascade in which unregulated kallikrein (KLK) 5 directly activates proteinase-activated receptor 2 and induces nuclear factor κB–mediated overexpression of TSLP, intercellular adhesion molecule 1, tumor necrosis factor α, and IL8. This proinflammatory and proallergic pathway is independent of the primary epithelial failure and is activated under basal conditions in NS keratinocytes. This cell-autonomous process is already established in the epidermis of Spink5−/− embryos, and the resulting proinflammatory microenvironment leads to eosinophilic and mast cell infiltration in a skin graft model in nude mice. Collectively, these data establish that uncontrolled KLK5 activity in NS epidermis can trigger atopic dermatitis (AD)–like lesions, independently of the environment and the adaptive immune system. They illustrate the crucial role of protease signaling in skin inflammation and point to new therapeutic targets for NS as well as candidate genes for AD and atopy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mutations or variants of genes such as SPINK5 favour the generation of allergen-independent, nonspecific inflammation, providing a pro-T helper 2 (TH2) micromilieu by virtue of keratinocyte-derived alarmins such as thymic stromal lymphopoietin (TSLP), IL-33 and IL-25 (refs52,64).”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [52]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The role of the innate immune system in the early phase of AD was demonstrated using animal models52–54 and is likely of clinical relevance in infancy55.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Williams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,599
Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP
Soumelis, V., Reche, P. A., Kanzler, H., Yuan, W., Edward, G., Homey, B., Gilliet, M., Ho, S., Antonenko, S., Lauerma, A., et al. (2002) · Nature Immunology · doi:10.1038/ni805 · Cited by 2,183
The cornified envelope: a model of cell death in the skin
Candi, E., Schmidt, R., & Melino, G. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1619 · Cited by 1,776
Atopic dermatitis and the atopic march
Spergel, J. M., & Paller, A. S. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.09.033 · Cited by 1,229
Leung, D. Y., & Bieber, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12193-9 · Cited by 1,147
Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes
Rheinwald, J. G., & Green, H. (1977) · Nature · doi:10.1038/265421a0 · Cited by 1,066
Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris
Smith, F. J. D., Irvine, A. D., Terron-Kwiatkowski, A., Sandilands, A., Campbell, L. E., Zhao, Y., Liao, H., Evans, A. T., Goudie, D. R., Lewis-Jones, S., et al. (2006) · Nature Genetics · doi:10.1038/ng1743 · Cited by 1,034 · cited 1×
“Recent genetic studies have shown that loss-of-function mutations in the gene encoding FILAGGRIN underlie ichthyosis vulgaris (6), a very common genetic disorder of keratinization.”
BackgroundMutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome
Chavanas, S., Bodemer, C., Rochat, A., Hamel-Teillac, D., Ali, M., Irvine, A. D., Bonafé, J.-L., Wilkinson, J., Taïeb, A., Barrandon, Y., et al. (2000) · Nature Genetics · doi:10.1038/75977 · Cited by 856 · cited 1×
“We previously identified serine protease inhibitor Kazal-type 5 (SPINK5) as the defective gene in NS (26).”
BackgroundSelf-citationγ-Secretase-mediated proteolysis in cell-surface-receptor signalling
Fortini, M. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm910 · Cited by 824
Allakhverdi, Z., Comeau, M. R., Jessup, H. K., Yoon, B.-R. P., Brewer, A., Chartier, S., Paquette, N., Ziegler, S. F., Sarfati, M., & Delespesse, G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062211 · Cited by 786
Proteinase-activated receptors: novel mechanisms of signaling by serine proteases
Déry, O., Corvera, C. U., Steinhoff, M., & Bunnett, N. W. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.6.c1429 · Cited by 779
Spergel, J. M., Mizoguchi, E., Brewer, J. P., Martin, T. R., Bhan, A. K., & Geha, R. S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1647 · Cited by 640
Yoo, J., Omori, M., Gyarmati, D., Zhou, B., Aye, T., Brewer, A., Comeau, M. R., Campbell, D. J., & Ziegler, S. F. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041503 · Cited by 613 · cited 4×
“The abundant and epidermally restricted TSLP secretion could induce an AD-like phenotype associated with elevated serum levels of IgE, as illustrated in Tslp skinspecific transgenic mice (21, 65).”
BackgroundInfluentialCytokines and chemokines orchestrate atopic skin inflammation
Homey, B., Steinhoff, M., Ruzicka, T., & Leung, D. Y. M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.03.047 · Cited by 579 · cited 1×
“AD has a complex etiology that results from interactions between environment and several susceptibility genes involved in skin barrier function and systemic and local immunological responses (10, 11).”
BackgroundThymic stromal lymphopoietin: master switch for allergic inflammation
Liu, Y.-J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051745 · Cited by 576
Cork, M. J., Robinson, D. A., Vasilopoulos, Y., Ferguson, A., Moustafa, M., MacGowan, A., Duff, G. W., Ward, S. J., & Tazi-Ahnini, R. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.04.042 · Cited by 525 · cited 1×
“AD has a complex etiology that results from interactions between environment and several susceptibility genes involved in skin barrier function and systemic and local immunological responses (10, 11).”
BackgroundNickoloff, B. J., & Naidu, Y. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70059-1 · Cited by 459 · cited 3×
“Nonetheless, IL-1 overexpression in Spink5/ embryos epidermis is likely to be a consequence of SC detachment that is already present before birth (17).”
BackgroundCutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.
Wood, L. C., Jackson, S. M., Elias, P. M., Grunfeld, C., & Feingold, K. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115884 · Cited by 454 · cited 2×
“Indeed, traumatic barrier disruption alone stimulates both keratinocyte proliferation and their cytokine and chemokine production (IL-1, IL-1, TNF-, and GM-CSF), characteristic features of skin inflammatory diseases (17, 18).”
BackgroundTransepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis
Werner, Y., & Lindberg, M. (1985) · Acta Dermato-Venereologica · doi:10.2340/0001555565102105 · Cited by 404 · cited 1×
“Clinically unaffected skin in AD manifests impaired skin barrier function that could favor the penetration of microbes and allergens (15), leading to the development of cutaneous and systemic allergies through activation of antigen-presenting cells such as Langerhans cells (LCs) (16).”
BackgroundHuman Thymic Stromal Lymphopoietin Preferentially Stimulates Myeloid Cells
Reche, P. A., Soumelis, V., Gorman, D. M., Clifford, T., Liu, M.-R., Travis, M., Zurawski, S. M., Johnston, J., Liu, Y.-J., Spits, H., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.336 · Cited by 403
Desmosomes: New Perspectives on a Classic
Green, K. J., & Simpson, C. L. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701015 · Cited by 402
Gene polymorphism in Netherton and common atopic disease
Walley, A. J., Chavanas, S., Moffatt, M. F., Esnouf, R. M., Ubhi, B., Lawrence, R., Wong, K., Abecasis, G. R., Jones, E. Y., Harper, J. I., et al. (2001) · Nature Genetics · doi:10.1038/ng728 · Cited by 401 · cited 1×
“Positive association was found in several studies in patients with different ethnical background (34, 36).”
ResultSelf-citationDescargues, P., Deraison, C., Bonnart, C., Kreft, M., Kishibe, M., Ishida-Yamamoto, A., Elias, P., Barrandon, Y., Zambruno, G., Sonnenberg, A., et al. (2005) · Nature Genetics · doi:10.1038/ng1493 · Cited by 383 · cited 7×
“IL-1 can be proteolytically activated by KLK7 (57), which is hyperactivated in Spink5/ skin (32).”
BackgroundMethodResultInfluentialSelf-citationZhang, W., Yang, H., Kong, X., Mohapatra, S., Juan-Vergara, H. S., Hellermann, G., Behera, S., Singam, R., Lockey, R. F., & Mohapatra, S. S. (2005) · Nature Medicine · doi:10.1038/nm1174 · Cited by 365
Lee, H.-C., & Ziegler, S. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607305104 · Cited by 339
Molecular models of the Intercellular Lipid Lamellae in Mammalian Stratum Corneum
Swartzendruber, D. C., Wertz, P. W., Kitko, D. J., Madison, K. C., & Downing, D. T. (1989) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12276794 · Cited by 336
Deraison, C., Bonnart, C., Lopez, F., Besson, C., Robinson, R., Jayakumar, A., Wagberg, F., Brattsand, M., Hachem, J. P., Leonardsson, G., et al. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-02-0124 · Cited by 329
Self-citationTumour necrosis factor haplotypes and asthma
Moffatt, M. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.4.551 · Cited by 274
A Unique Case of Trichorrhexis Nodosa—"Bamboo Hairs"
NETHERTON, E. W. (1958) · Archives of Dermatology · doi:10.1001/archderm.1958.01560100059009 · Cited by 262 · cited 1×
“NS is a rare (1 in 100,000 newborns) autosomal recessive skin disorder characterized by generalized exfoliative erythroderma, a specific hair shaft defect (trichorrhexis invaginata) and severe atopic manifestations, which distinguish NS from the other ichthyoses (22, 23).”
BackgroundCoughlin, S. R., & Camerer, E. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17564 · Cited by 251
Mechanisms of Desensitization and Resensitization of Proteinase-activated Receptor-2
Bühm, S. K., Khitin, L. M., Grady, E. F., Aponte, G., Payan, D. G., & Bunnett, N. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.22003 · Cited by 250
Thymic stromal lymphopoietin in normal and pathogenic T cell development and function
Ziegler, S. F., & Liu, Y.-J. (2006) · Nature Immunology · doi:10.1038/ni1360 · Cited by 230
Filaggrin null mutations are associated with increased asthma severity in children and young adults
Palmer, C. N. A., Ismail, T., Lee, S. P., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Smith, F. J. D., McLean, W. H. I., & Mukhopadhyay, S. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.001 · Cited by 229 · cited 1×
“The same FILAGGRIN mutations have also been identified as a major risk factor for atopic dermatitis (AD) and are strongly associated with asthma in AD patients (7, 8).”
BackgroundFilaggrin Mutations in Children with Severe Atopic Dermatitis
Morar, N., Cookson, W. O. C. M., Harper, J. I., & Moffatt, M. F. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700739 · Cited by 221 · cited 1×
“The same FILAGGRIN mutations have also been identified as a major risk factor for atopic dermatitis (AD) and are strongly associated with asthma in AD patients (7, 8).”
BackgroundBitoun, E. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg247 · Cited by 212 · cited 3×
“histochemical analysis of skin sections as previously described (27).”
BackgroundThe Ichthyoses: A Guide to Clinical Diagnosis, Genetic Counseling and Therapy
Traupe, H. (1989) · Medical Entomology and Zoology · Cited by 202
Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population
Kato, A., Fukai, K., Oiso, N., Hosomi, N., Murakami, T., & Ishii, M. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05243.x · Cited by 198
Descargues, P., Deraison, C., Prost, C., Fraitag, S., Mazereeuw-Hautier, J., D'Alessio, M., Ishida-Yamamoto, A., Bodemer, C., Zambruno, G., & Hovnanian, A. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700284 · Cited by 196
Self-citationEbner, S., Nguyen, V. A., Forstner, M., Wang, Y.-H., Wolfram, D., Liu, Y.-J., & Romani, N. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.01.003 · Cited by 188 · cited 2×
“In addition, in an immunecompetent system, TSLP has the potential to activate dendritic cells and epidermal LCs in particular, triggering the generation of proallergic CD4+ Th2 cells (19, 20, 64).”
BackgroundElias, P. M., Williams, M. L., Holleran, W. M., Jiang, Y. J., & Schmuth, M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800002-jlr200 · Cited by 186 · cited 1×
“Alterations in these processes, as well as mutations in genes encoding proteins involved in terminal differentiation, can lead to abnormal stratification and keratinization, as seen in ichthyoses (5).”
BackgroundDemehri, S., Liu, Z., Lee, J., Lin, M.-H., Crosby, S. D., Roberts, C. J., Grigsby, P. W., Miner, J. H., Farr, A. G., & Kopan, R. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060123 · Cited by 174
A clinical and immunological study of Netherton's syndrome
JUDGE, M. R., MORGAN, G., & HARPER, J. I. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb04971.x · Cited by 164 · cited 1×
“Indeed, NS patients suffer from recurrent AD with elevated serum IgE levels, asthma, and multiple food allergies (24, 25).”
BackgroundMiike, S., McWilliam, A. S., & Kita, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6615 · Cited by 154
Association between polymorphisms in the SPINK5 gene and atopic dermatitis in the Japanese
Nishio, Y., Noguchi, E., Shibasaki, M., Kamioka, M., Ichikawa, E., Ichikawa, K., Umebayashi, Y., Otsuka, F., & Arinami, T. (2003) · Genes and Immunity · doi:10.1038/sj.gene.6363889 · Cited by 151
Ichthyosis linearis circumflexa
Comèl, M. (2009) · Dermatologica · doi:10.1159/000257290 · Cited by 142
Analysis of SPINK 5, KLK 7 and FLG Genotypes in a French Atopic Dermatitis Cohort
Hubiche, T., Ged, C., Benard, A., Léauté-Labrèze, C., McElreavey, K., de Verneuil, H., Taïeb, A., & Boralevi, F. (2007) · Acta Dermato-Venereologica · doi:10.2340/00015555-0329 · Cited by 133
Buddenkotte, J., Stroh, C., Engels, I. H., Moormann, C., Shpacovitch, V. M., Seeliger, S., Vergnolle, N., Vestweber, D., Luger, T. A., Schulze‐Osthoff, K., et al. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23539.x · Cited by 132
Seeliger, S., Derian, C. K., Vergnolle, N., Bunnett, N. W., Nawroth, R., Schmelz, M., Von Der Weid, P.-Y., Buddenkotte, J., Sunderkötter, C., Metze, D., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-1112com · Cited by 125
Moormann, C., Artuc, M., Pohl, E. E., Varga, G., Buddenkotte, J., Vergnolle, N., Brehler, R., Henz, B. M., Schneider, S. W., Luger, T. A., et al. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700169 · Cited by 122
HOU, L., KAPAS, S., CRUCHLEY, A. T., MACEY, M. G., HARRIOTT, P., CHINNI, C., STONE, S. R., & HOWELLS, G. L. (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00528.x · Cited by 121
Temkin, V., Kantor, B., Weg, V., Hartman, M.-L., & Levi-Schaffer, F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2662 · Cited by 120
hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6
Egelrud, T., Brattsand, M., Kreutzmann, P., Walden, M., Vitzithum, K., Marx, U. C., Forssmann, W. G., & Magert, H. J. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06834.x · Cited by 118
Atopic march: link to upper airways
Spergel, J. M. (2005) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200502000-00005 · Cited by 116
Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs)
Oikonomopoulou, K., Hansen, K. K., Saifeddine, M., Vergnolle, N., Tea, I., Blaber, M., Blaber, S. I., Scarisbrick, I., Diamandis, E. P., & Hollenberg, M. D. (2006) · Biological Chemistry · doi:10.1515/bc.2006.104 · Cited by 115
Homey, B., & Zlotnik, A. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00028-x · Cited by 113
Kabesch, M., Carr, D., Weiland, S. K., & von Mutius, E. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.01860.x · Cited by 109
Yang, T., Liang, D., Koch, P. J., Hohl, D., Kheradmand, F., & Overbeek, P. A. (2004) · Genes & Development · doi:10.1101/gad.1232104 · Cited by 105
Schechter, N. M., Choi, E.-J., Wang, Z.-M., Hanakawa, Y., Stanley, J. R., Kang, Y., Clayman, G. L., & Jayakumar, A. (2005) · Biological Chemistry · doi:10.1515/bc.2005.134 · Cited by 101
Nylander-Lundqvist, E., & Egelrud, T. (1997) · Acta Dermato Venereologica · doi:10.2340/0001555577203206 · Cited by 101
New Techniques for the Grafting of Cultured Human Epidermal Cells onto Athymic Animals
Barrandon, Y., Li, V. W., & Green, H. (1988) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12475646 · Cited by 100
Desquamation in the Stratum Corneum
Egelrud, T. (2000) · Acta Dermato-Venereologica · doi:10.1080/000155500750012513 · Cited by 95 · cited 1×
“Proteolytic degradation of corneodesmosomes by epidermal proteases leads to the shedding of the most superficial corneocytes (4).”
BackgroundHewett, D. R., Simons, A. L., Mangan, N. E., Jolin, H. E., Green, S. M., Fallon, P. G., & McKenzie, A. N. J. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddi030 · Cited by 94
Skin Barrier Dysfunction and Systemic Sensitization to Allergens Through the Skin
Strid, J., & Ströbel, S. (2005) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/156801005774322199 · Cited by 80
Protease-Activated Receptor-2 Signaling Triggers Dendritic Cell Development
Fields, R. C., Schoenecker, J. G., Hart, J. P., Hoffman, M., Pizzo, S. V., & Lawson, J. H. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64316-7 · Cited by 76
Tumour necrosis factor stimulates human skin mast cells to release histamine and tryptase
van Overveld, F. J., Jorens, P. G., Rampart, M., Backer, W. D., & Vermeire, P. A. (1991) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1991.tb03200.x · Cited by 71
The pathophysiology of atopic eczema.
Allam, J., & Novak, N. (2005) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2005.01980.x · Cited by 64 · cited 1×
“Clinically unaffected skin in AD manifests impaired skin barrier function that could favor the penetration of microbes and allergens (15), leading to the development of cutaneous and systemic allergies through activation of antigen-presenting cells such as Langerhans cells (LCs) (16).”
BackgroundFölster‐Holst, R., Stoll, M., Koch, W. A., Hampe, J., Christophers, E., & Schreiber, S. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06602.x · Cited by 55
SPINK5: A gene for atopic dermatitis and asthma
Moffatt, M. F. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.01915.x · Cited by 54
Polymorphisms in SPINK5 are not associated with asthma in a Dutch population
Jongepier, H., Koppelman, G. H., Nolte, I. M., Bruinenberg, M., Bleecker, E. R., Meyers, D. A., Meerman, G. J. T., & Postma, D. S. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.12.013 · Cited by 49
Kobayashi, M., Asano, H., Fujita, Y., & Hoshino, T. (1987) · Cell and Tissue Research · doi:10.1007/bf00218198 · Cited by 35
Ny, A., & Egelrud, T. (2003) · Acta Dermato Venereologica · doi:10.1080/00015550310003809 · Cited by 21
Cited by
Filaggrin Mutations Associated with Skin and Allergic Diseases
Irvine, A. D., McLean, W. H. I., & Leung, D. Y. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011040 · Cited by 1,217
Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., et al. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14891 · Cited by 1,181
The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch
Wilson, S. R., Thé, L., Batia, L. M., Beattie, K., Katibah, G. E., McClain, S. P., Pellegrino, M., Estandian, D. M., & Bautista, D. M. (2013) · Cell · doi:10.1016/j.cell.2013.08.057 · Cited by 987
Guidelines for treatment of atopic eczema (atopic dermatitis) Part I
Ring, J., Alomar, A., Bieber, T., Deleuran, M., Fink‐Wagner, A., Gelmetti, C., Gieler, U., Lipozencic, J., Luger, T., Oranje, A. P., et al. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04635.x · Cited by 683
“Barrier disruption leads to inflammation, and protease-antiprotease imbalance is a crucial intermediate step (Briot et al. 2009).”
BackgroundAtopic dermatitis: an expanding therapeutic pipeline for a complex disease
Bieber, T. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00266-6 · Cited by 623
Metadata
- Authors
- Briot, A., Deraison, C., Lacroix, M., Bonnart, C., Robin, A., Besson, C., Dubus, P., & Hovnanian, A.
- Affiliations
- Université Toulouse III - Paul Sabatier (FR)
- Institut National de la Santé et de la Recherche Médicale, U563, Toulouse F-31300, France 1
- Université Bordeaux Segalen (FR)
- Corresponding author
- Hovnanian, Alain
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2009-05-04
- Volume
- 206
- Issue
- 5
- Pages
- 1135-1147
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2715042
- OpenAlex
- W2144344238
- Cited by
- 504
- References
- 71
- Citations by year
- 2026: 17 · 2025: 14 · 2024: 22 · 2023: 18 · 2022: 32 · 2021: 24 · 2020: 30 · 2019: 37 · 2018: 22 · 2017: 31 · 2016: 40 · 2015: 30 · 2014: 42 · 2013: 42 · 2012: 33
- FWCI
- 42.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-05-MRAR-0009)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
- Health Sciences › Medicine › Dermatology › Genetic and rare skin diseases.
- Keywords
- Netherton syndrome, kallikrein 5, SPINK5, LEKTI, atopic dermatitis, protease-activated receptor 2, thymic stromal lymphopoietin, keratinocytes, NF-κB signaling, Th2 cytokines, skin barrier dysfunction, eosinophilic dermatitis, mast cell infiltration, protease signaling, atopy
- MeSH terms
- Serine Peptidase Inhibitor Kazal-Type 5, Animals, Dermatitis, Atopic, Epidermis, Inflammation, Kallikreins, Mice, Nude, Skin, Serpins, Skin Transplantation, Mice, Knockout, Dermis, Mice, Keratin-14
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.